Catalyst Wire Dossier Catalyst Wire Dossier

aripiprazole/escitalopram combination therapy

· Otsuka Pharmaceutical Development & Commercialization, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for aripiprazole/escitalopram combination therapy, covering 2021-12-21 to 2021-12-22. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) [Phase 3]

See pricing